Animal Models of Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease

Pentela Mohana Lakshmi; Jorige Archana

doi:10.52711/2231-5691.2025.00009

Asian Journal of Pharmaceutical Research

ISSN

2231-5691 (Online)
2231-5683 (Print)

Submit Article

Animal Models of Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease

Author(s): Pentela Mohana Lakshmi, Jorige Archana

Email(s): pmohanalakshmi49@gmail.com

DOI: 10.52711/2231-5691.2025.00009

Address: Pentela Mohana Lakshmi*, Jorige Archana
Department of Pharmacology, RBVRR Women’s College of Pharmacy (Affiliated to Osmania University) Barkatpura, Hyderabad – 500027.
*Corresponding Author

Published In: Volume - 15, Issue - 1, Year - 2025

View HTML

Purchase PDF

ABSTRACT:
The alcoholic liver disease (ALD) and Non-alcoholic fatty liver disease include the lethal factors for chronic hepatic lipid deposition, inflammatory events to extensive fibrotic repair globally that is responsible for a major clinical contribution. Based on these findings, we observed that alcohol induced liver diseases (ALD) is caused by oxidant: antioxidant imbalance. As animal models and in vitro research have clarified the complex biochemical mechanisms involved, treatment with antioxidants, anti-inflammatory drugs and enzyme inhibitors that block alcohol metabolism has been explored. Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis and is often linked to obesity, insulin resistance, and dyslipidemia. It is caused by adipose tissue failure, insulin signaling pathways, and inflammatory mediators. Preclinical models targeting these processes are crucial.

Keywords:

Cite this article:
Pentela Mohana Lakshmi, Jorige Archana. Animal Models of Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease. Asian Journal of Pharmaceutical Research. 2025; 15(1):51-9. doi: 10.52711/2231-5691.2025.00009

Cite(Electronic):
Pentela Mohana Lakshmi, Jorige Archana. Animal Models of Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease. Asian Journal of Pharmaceutical Research. 2025; 15(1):51-9. doi: 10.52711/2231-5691.2025.00009 Available on: https://asianjpr.com/AbstractView.aspx?PID=2025-15-1-9

REFERENCES:
1.    Lieber cs, jones dp, decarli lm. effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest. 1965; Jun; 44(6): 1009-21. doi: 10.1172/JCI105200.
2.    Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; Nov; 141(5): 1572-85. doi: 10.1053/j.gastro.2011.09.002.
3.    Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015; Apr; 12(4): 231-42. doi: 10.1038/nrgastro.2015.35.
4.    Lieber CS. Metabolism of alcohol. Clin Liver Dis. 2005; Feb; 9(1): 1-35. doi: 10.1016/j.cld.2004.10.005.
5.    Cederbaum AI. Cytochrome P450 2E1-dependent oxidant stress and upregulation of anti-oxidant defense in liver cells. J Gastroenterol Hepatol. 2006; Oct; 21 Suppl 3: S22-5. doi: 10.1111/j.1440-1746.2006.04595.x.
6.    Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012; Nov; 16(4): 667-85. doi: 10.1016/j.cld.2012.08.002.
7.    Espina N, Lima V, Lieber CS, Garro AJ. In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6-methylguanine transferase. Carcinogenesis. 1988; May; 9(5): 761-6. doi: 10.1093/carcin/9.5.761.
8.    Müller A, Sies H. Role of alcohol dehydrogenase activity and the acetaldehyde in ethanol- induced ethane and pentane production by isolated perfused rat liver. Biochem J. 1982; Jul 15; 206(1): 153-6. doi: 10.1042/bj2060153.
9.    C S Lieber, E Baraona, R Hernández-Muñoz, S Kubota, N Sato, S Kawano, T Matsumura, and N InatomiImpaired oxygen utilization. A new mechanism for the hepatotoxicity of ethanol in sub-human primates. 1989; 83(5): 1682–1690. https://doi.org/10.1172/JCI114068
10.    Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; May; 134(6): 1655-69. doi: 10.1053/j.gastro.2008.03.003.
11.    Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; Feb; 115(2): 209-18. doi: 10.1172/JCI24282.
12.    Cubero FJ, Urtasun R, Nieto N. Alcohol and liver fibrosis. Semin Liver Dis. 2009; May; 29(2): 211-21. doi: 10.1055/s-0029-1214376.
13.    Mello T, Ceni E, Surrenti C, Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med. 2008; Feb-Apr; 29(1-2): 17-21. doi: 10.1016/j.mam.2007.10.001.
14.    Thurman RG, Bradford BU, Iimuro Y, Knecht KT, Connor HD, Adachi Y, Wall C, Arteel GE, Raleigh JA, Forman DT, Mason RP. Role of Kupffer cells, endotoxin and free radicals in hepatotoxicity due to prolonged alcohol consumption: studies in female and male rats. J Nutr. 1997; May; 127(5 Suppl):903S-906S. doi: 10.1093/jn/127.5.903S.
15.    Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 2010; Mar 21; 16(11): 1321-9. doi: 10.3748/wjg.v16.i11.1321.
16.    Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007; Nov; 13(11): 1324-32. doi: 10.1038/nm1663.
17.    Jagavelu K, Routray C, Shergill U, O'Hara SP, Faubion W, Shah VH. Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver. Hepatology. 2010; Aug; 52(2): 590-601. doi: 10.1002/hep.23739.
18.    Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res. 2011; Aug; 35(8): 1509-18. doi: 10.1111/j.1530-0277.2011.01487.x.
19.    Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004; Nov; 127(5 Suppl 1): S87-96. doi: 10.1053/j.gastro.2004.09.020.
20.    McKillop IH, Schrum LW. Role of alcohol in liver carcinogenesis. Semin Liver Dis. 2009; May; 29(2): 222-32. doi: 10.1055/s-0029-1214377.
21.    BEST CH, HARTROFT WS, et al. Liver damage produced by feeding alcohol or sugar and its prevention by choline. Br Med J. 1949; Nov 5; 2(4635): 1002-6, pl. doi: 10.1136/bmj.2.4635.1001.
22.    Charles S. Lieber M.D. 1, Leonore M. DeCarli B.A. Study of agents for the prevention of the fatty liver produced by prolonged alcohol intake https://doi.org/10.1016/S0016-5085(66)80070-7
23.    DeCarli LM, Lieber CS. Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet. J Nutr. 1967; Mar; 91(3): 331-6. doi: 10.1093/jn/91.3_Suppl.331.
24.    Lieber CS, DeCarli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science. 1968 Nov 22; 162(3856): 917-8. doi: 10.1126/science.162.3856.917.
25.    Lieber CS, DeCarli LM. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res. 1982; Fall; 6(4): 523-31. doi: 10.1111/j.1530-0277.1982.tb05017.x.
26.    Lieber CS, DeCarli LM. Liquid diet technique of ethanol administration: 1989 update. Alcohol Alcohol. 1989; 24(3): 197-211.
27.    de la M Hall P, Lieber CS, DeCarli LM, French SW, Lindros KO, Järveläinen H, Bode C, Parlesak A, Bode JC. Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res. 2001; May; 25(5 Suppl ISBRA): 254S-261S. doi: 10.1097/00000374-200105051-00041.
28.    Lamas-Paz A, Hao F, Nelson LJ, Vázquez MT, Canals S, Gómez Del Moral M, Martínez-Naves E, Nevzorova YA, Cubero FJ. Alcoholic liver disease: Utility of animal models. World J Gastroenterol. 2018; Dec 7; 24(45): 5063-5075. doi: 10.3748/wjg.v24.i45.5063.
29.    Varghese J, James JV, Sagi S, Chakraborty S, Sukumaran A, Ramakrishna B, Jacob M. Decreased hepatic iron in response to alcohol may contribute to alcohol-induced suppression of hepcidin. Br J Nutr. 2016; Jun; 115(11): 1978-86. doi: 10.1017/S0007114516001197.
30.    Guo F, Zheng K, Benedé-Ubieto R, Cubero FJ, Nevzorova YA. The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease. Alcohol Clin Exp Res. 2018; Oct; 42(10): 1828-1840. doi: 10.1111/acer.13840.
31.    Nevzorova YA, Cubero FJ, Hu W, Hao F, Haas U, Ramadori P, Gassler N, Hoss M, Strnad P, Zimmermann HW, Tacke F, Trautwein C, Liedtke C. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. J Hepatol. 2016; Mar; 64(3): 628-40. doi: 10.1016/j.jhep.2015.11.005.
32.    Tammen SA, Dolnikowski GG, Ausman LM, Liu Z, Sauer J, Friso S, Choi SW. Aging and alcohol interact to alter hepatic DNA hydroxymethylation. Alcohol Clin Exp Res. 2014; Aug; 38(8): 2178-85. doi: 10.1111/acer.12477.
33.    Park JK, Shao M, Kim MY, Baik SK, Cho MY, Utsumi T, Satoh A, Ouyang X, Chung C, Iwakiri Y. An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization. Hepatology. 2017; May; 65(5): 1720-1734. doi: 10.1002/hep.29051.
34.    Ambade A, Satishchandran A, Gyongyosi B, Lowe P, Szabo G. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease. World J Gastroenterol. 2016; Apr 28; 22(16): 4091-108. doi: 10.3748/wjg.v22.i16.4091.
35.    Alund AW, Mercer KE, Pulliam CF, Suva LJ, Chen JR, Badger TM, Ronis MJ. Partial Protection by Dietary Antioxidants Against Ethanol-Induced Osteopenia and Changes in Bone Morphology in Female Mice. Alcohol Clin Exp Res. 2017; Jan; 41(1): 46-56. doi: 10.1111/acer.13284.
36.    Sun Q, Zhong W, Zhang W, Zhou Z. Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency. Am J Physiol Gastrointest Liver Physiol. 2016; Feb 1; 310(3): G205-14. doi: 10.1152/ajpgi.00270.2015.
37.    Cubero FJ, Nieto N. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. Hepatology. 2008; Dec; 48(6): 2027-2039. doi: 10.1002/hep.22592.
38.    Leo MA, Lieber CS. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology. 1983; Jan-Feb; 3(1): 1-11. doi: 10.1002/hep.1840030101.
39.    Aroor AR, Jackson DE, Shukla SD. Elevated activation of ERK1 and ERK2 accompany enhanced liver injury following alcohol binge in chronically ethanol-fed rats. Alcohol Clin Exp Res. 2011; Dec; 35(12): 2128-38. doi: 10.1111/j.1530-0277.2011.01577.x.
40.    Marhenke S, Buitrago-Molina LE, Endig J, Orlik J, Schweitzer N, Klett S, Longerich T, Geffers R, Sánchez Muñoz A, Dorrell C, Katz SF, Lechel A, Weng H, Krech T, Lehmann U, Dooley S, Rudolph KL, Manns MP, Vogel A. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury. Gut. 2014; Sep; 63(9): 1501-12. doi: 10.1136/gutjnl-2013-304829.
41.    Shukla SD, Pruett SB, Szabo G, Arteel GE. Binge ethanol and liver: new molecular developments. Alcohol Clin Exp Res. 2013; Apr; 37(4): 550-7. doi: 10.1111/acer.12011.
42.    Rafacho BP, Stice CP, Liu C, Greenberg AS, Ausman LM, Wang XD. Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice. Hepatobiliary Surg Nutr. 2015; Apr; 4(2): 124-34. doi: 10.3978/j.issn.2304-3881.2014.08.06.
43.    Muñoz NM, Katz LH, Shina JH, Gi YJ, Menon VK, Gagea M, Rashid A, Chen J, Mishra L. Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruption. Genes Cancer. 2014; Sep; 5(9-10): 348-352. doi: 10.18632/genesandcancer.32.
44.    McCuskey RS, Bethea NW, Wong J, McCuskey MK, Abril ER, Wang X, Ito Y, DeLeve LD. Ethanol binging exacerbates sinusoidal endothelial and parenchymal injury elicited by acetaminophen. J Hepatol. 2005; Mar; 42(3): 371-7. doi: 10.1016/j.jhep.2004.11.033.
45.    Best CH, Hartroft WS, et al. Liver damage produced by feeding alcohol or sugar and its prevention by choline. Br Med J. 1949; Nov 5; 2(4635): 1002-6, pl. doi: 10.1136/bmj.2.4635.1001.
46.    Brandon-Warner E, Walling TL, Schrum LW, McKillop IH. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res. 2012; Apr; 36(4): 641-53. doi: 10.1111/j.1530-0277.2011.01660.x.
47.    Keegan A, Martini R, Batey R. Ethanol-related liver injury in the rat: a model of steatosis, inflammation and pericentral fibrosis. J Hepatol. 1995; Nov; 23(5): 591-600. doi: 10.1016/0168-8278(95)80067-0.
48.    Cook RT, Schlueter AJ, Coleman RA, Tygrett L, Ballas ZK, Jerrells TR, Nashelsky MB, Ray NB, Haugen TH, Waldschmidt TJ. Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion--absence of subset-specific glucocorticoid-induced immune cell loss. Alcohol Clin Exp Res.doi: 10.1111/j.1530-0277.2007.00478.x.
49.    Song M, Chen T, Prough RA, Cave MC, McClain CJ. Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response. Alcohol Clin Exp Res. 2016; Mar; 40(3): 518-28. doi: 10.1111/acer.12994.
50.    Meadows GG, Blank SE, Duncan DD. Influence of ethanol consumption on natural killer cell activity in mice. Alcohol Clin Exp Res. 1989; Aug; 13(4): 476-9. doi: 10.1111/j.1530-0277.1989.tb00359.x.
51.    McCaskill ML, Hottor HT, Sapkota M, Wyatt TA. Dietary diallyl disulfide supplementation attenuates ethanol-mediated pulmonary vitamin D speciate depletion in C57Bl/6 mice. BMC Nutr. 2015; 1: 18. doi: 10.1186/s40795-015-0012-z.
52.    An TC, Crawford DH, Jaskowski LA, Subramaniam VN, Clouston AD, Crane DI, Bridle KR, Anderson GJ, Fletcher LM. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest. 2013; Dec; 93(12): 1295-312. doi: 10.1038/labinvest.2013.121.
53.    Abraham P, Wilfred G, Ramakrishna B. Oxidative damage to the hepatocellular proteins after chronic ethanol intake in the rat. Clin Chim Acta. 2002; Nov; 325(1-2): 117-25. doi: 10.1016/s0009-8981(02)00279-6.
54.    Lamas-Paz A, Hao F, Nelson LJ, Vázquez MT, Canals S, Gómez Del Moral M, Martínez-Naves E, Nevzorova YA, Cubero FJ. Alcoholic liver disease: Utility of animal models. World J Gastroenterol. 2018; Dec 7; 24(45): 5063-5075. doi: 10.3748/wjg.v24.i45.5063.
55.    Tsukamoto H, Reidelberger RD, French SW, Largman C. Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol. 1984; Sep; 247(3 Pt 2): R595-9. doi: 10.1152/ajpregu.1984.247.3.R595.
56.    Ueno A, Lazaro R, Wang PY, Higashiyama R, Machida K, Tsukamoto H. Mouse intragastric infusion (iG) model. Nat Protoc. 2012; Mar 29; 7(4): 771-81. doi: 10.1038/nprot.2012.014.
57.    Tsukamoto H, French SW, Benson N, Delgado G, Rao GA, Larkin EC, Largman C. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology. 1985; Mar-Apr; 5(2): 224-32. doi: 10.1002/hep.1840050212.
58.    Tsukamoto H, Towner SJ, Ciofalo LM, French SW. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology. 1986; Sep-Oct; 6(5): 814-22. doi: 10.1002/hep.1840060503
59.    Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, Brittenham GM. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest. 1995; Jul; 96(1): 620-30. doi: 10.1172/JCI118077.
60.    Nanji AA, French SW. Animal models of alcoholic liver disease--focus on the intragastric feeding model. Alcohol Res Health. 2003
61.    French SW. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J Biomed Sci. 2001 Jan-Feb;8(1):20-7. doi: 10.1007/BF02255967.
62.    Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res. 1989 Feb; 13(1): 15-9. doi: 10.1111/j.1530-0277.1989.tb00276.x.
63.    Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology. 2005; Oct; 42(4): 905-14. doi: 10.1002/hep.20877.
64.    Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 2013; Mar; 8(3): 627-37. doi: 10.1038/nprot.2013.032.
65.    Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH. Rodent models of alcoholic liver disease: of mice and men. Alcohol. doi: 10.1016/j.alcohol.2012.08.004.
66.    Guo F, Zheng K, Benedé-Ubieto R, Cubero FJ, Nevzorova YA. The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease. Alcohol Clin Exp Res. 2018; Oct; 42(10): 1828-1840. doi: 10.1111/acer.13840.
67.    Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990; Nov; 12(5): 1106-10. doi: 10.1002/hep.1840120505.
68.    Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T. Liver fibrosis in overweight patients. Gastroenterology. 2000; Jun; 118(6): 1117-23. doi: 10.1016/s0016-5085(00)70364-7.
69.    Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999; Nov; 107(5): 450-5. doi: 10.1016/s0002-9343(99)00271-5.
70.    Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013; May 10; 5(5): 1544-60. doi: 10.3390/nu5051544.
71.    Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol. 2013; Nov; 10(11): 627-36. doi: 10.1038/nrgastro.2013.149.
72.    Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM. 2010; Feb; 103(2): 71-83. doi: 10.1093/qjmed/hcp158.
73.    Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010; May; 51(5): 1820-32. doi: 10.1002/hep.23594.
74.    Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Ünalp-Arida A, Wilson LA, Chalasani N. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol. 2011; Sep; 55(3): 654-659. doi: 10.1016/j.jhep.2010.11.021.
75.    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; Sep;94(9): 2467-74. doi: 10.1111/j.1572-0241.1999.01377.x.
76.    Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006; Feb; 87(1): 1-16. doi: 10.1111/j.0959-9673.2006.00465.x.
77.    Bradbury MW, Berk PD. Lipid metabolism in hepatic steatosis. Clin Liver Dis. 2004; Aug; 8(3): 639-71, xi. doi: 10.1016/j.cld.2004.04.005.
78.    Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002; Oct; 16(5): 663-78. doi: 10.1053/bega.2002.0333.
79.    Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008; Jul; 114(3): 183-94. doi: 10.1080/13813450802181047.
80.    Medina J, Fernández-Salazar LI, García-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care. 2004; Aug; 27(8): 2057-66. doi: 10.2337/diacare.27.8.2057.
81.    Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2004; Jun; 106(6): 635-43. doi: 10.1042/CS20030326.
82.    Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie. 2005; Jan; 87(1): 81-6. doi: 10.1016/j.biochi.2004.11.008.
83.    Hamel FG, Bennett RG, Upward JL, Duckworth WC. Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. Endocrinology. 2001; Jun; 142(6): 2702-6. doi: 10.1210/endo.142.6.8178.
84.    Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis. 2009; Sep; 41(9): 615-25. doi: 10.1016/j.dld.2009.01.004.
85.    Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001; Apr; 120(5): 1183-92. doi: 10.1053/gast.2001.23256.
86.    George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol. 2003; Nov; 39(5): 756-64. doi: 10.1016/s0168-8278(03)00376-3.
87.    Reddy JK. Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2001; Dec; 281(6): G1333-9. doi: 10.1152/ajpgi.2001.281.6.G1333.
88.    Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):179-85. doi: 10.1159/000282083.
89.    Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM. Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2004; Mar; 79(3): 502-9. doi: 10.1093/ajcn/79.3.502.
90.    Fakhoury-Sayegh N, Trak-Smayra V, Khazzaka A, Esseily F, Obeid O, Lahoud-Zouein M, Younes H. Characteristics of nonalcoholic fatty liver disease induced in wistar rats following four different diets. Nutr Res Pract. 2015; Aug; 9(4): 350-7. doi: 10.4162/nrp.2015.9.4.350.
91.    Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002; Aug; 37(2): 206-13. doi: 10.1016/s0168-8278(02)00102-2. .
92.    Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol. 2004; Nov; 287(5): G1035-43. doi: 10.1152/ajpgi.00199.2004.
93.    Yamada T, Obata A, Kashiwagi Y, Rokugawa T, Matsushima S, Hamada T, Watabe H, Abe K. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. Magn Reson Imaging. 2016; Jul; 34(6): 724-729. doi: 10.1016/j.mri.2016.03.009.
94.    Lee SJ, Kang JH, Iqbal W, Kwon OS. Proteomic analysis of mice fed methionine and choline deficient diet reveals marker proteins associated with steatohepatitis. PLoS One. 2015; Apr 7; 10(4): e0120577. doi: 10.1371/journal.pone.0120577.
95.    Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology. 2013; Jan; 57(1): 81-92. doi: 10.1002/hep.25789.
96.    Farrell GC, Mridha AR, Yeh MM, Arsov T, Van Rooyen DM, Brooling J, Nguyen T, Heydet D, Delghingaro-Augusto V, Nolan CJ, Shackel NA, McLennan SV, Teoh NC, Larter CZ. Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. Liver Int. 2014; Aug; 34(7): 1084-93. doi: 10.1111/liv.12335.

Recomonded Articles:

Pharmacological and Phytochemical Evidences for the Plants of Wedelia Genus– A Review

Author(s): AK Meena, MM Rao, RP Meena, P Panda, Renu

DOI: Access: Open Access Read More

Traditional Herbs to treat Acne Vulgaris

Author(s): Sonali Syal, Vinay Pandit, M. S Ashawat

DOI: 10.5958/2231-5691.2020.00034.9 Access: Open Access Read More

Eupatorium triplinerve (Vahl): An Ethnobotanical Review

Author(s): Binoy Varghese Cheriyan, Sabartina scarlet, Priyadarshini, Shailesh joshi, Santhseelan, Sheik Mohamed

DOI: 10.5958/2231-5691.2019.00032.7 Access: Open Access Read More

A detailed investigation of phytochemical, biological and commercial utilization of horse tail tree Casuarina equisetifolia

Author(s): Vani Mamillapalli, Latha Sri Kondaveeti, Ratna Harika Chapala, Tejaswi Komal Sai. Sareddu, Santhi Pattipati, Padmalatha Khantamneni

DOI: 10.52711/2231-5691.2022.00014 Access: Open Access Read More

Animal Models for Inflammation: A Review

Author(s): Ghanshyam Dhalendra, Trilochan Satapathy, Amit Roy

DOI: Access: Open Access Read More

Evaluation of Wound Healing Activity of Ethanolic Extract of Curcuma longa Rhizomes in Male Albino Rats

Author(s): S.K. Purohit, R. Solanki, V. Mathur, M. Mathur

DOI: Access: Open Access Read More

Phytopharmacology of Ficus bengalensis - A Review

Author(s): Prathap Kumar Kothapalli, Jagadeesh. S. Sanganal, N.B. Shridhar

DOI: Access: Open Access Read More

Anti-Inflammatory activity of Ethanolic extract of Basella alba in acute and Sub-acute Model

Author(s): Naidu Narapusetty, O. Sivaiah, B. Balanasaraiah, M. Haranadhbabu, B. Prasad, B. Hosanna Crown, Ch. M. M. Prasada Rao

DOI: 10.5958/2231-5691.2017.00015.6 Access: Open Access Read More

Formulation and Evaluation of Herbal Shampoo: Bryophyllum pinnatum

Author(s): Kavya V. Reddy, Ashish V. Yachawad, Krushna K. Zambare, Sopan Landge

DOI: 10.5958/2231-5691.2020.00016.7 Access: Open Access Read More

Effects of Anti-Inflammatory Activity of Mimosa pudica.

Author(s): Venkateshwarlu Goli, Kanakam Vijay Bhaskar, Sravan Prasad Macharla, Jimmidi.Bhaskar, P. Suvarna Devi, T. Ramchander

DOI: Access: Open Access Read More

Calotropis gigantea: A brief Study on Phytochemical and Pharmacological Profile

Author(s): Subhajit Mandal

DOI: 10.52711/2231-5691.2023.00006 Access: Open Access Read More

Murrayanine-Chalcone Transformed into Novel Pyrimidine Compounds Demonstrated promising Anti-Inflammatory Activity

Author(s): Debarshi Kar Mahapatra, Ruchi S. Shivhare, Pranesh Kumar

DOI: 10.5958/2231-5691.2018.00002.3 Access: Open Access Read More

Antioxidant Activity of Cinnamon zeylanicum: (A Review)

Author(s): Muhammad Hamza Ashfaq, Amna Siddique, Sammia Shahid

DOI: 10.52711/2231-5691.2021.00021 Access: Open Access Read More

Review on Anti-inflammatory Properties of Mangrove plants

Author(s): P. Lalitha, V. Sachithanandam, N. S. Swarnakumar, R. Sridhar

DOI: 10.5958/2231-5691.2019.00045.5 Access: Open Access Read More

Ethnobotanical studies on plants used in folk medicines in cure of Diabetes in Gondwana Region of Madhya Pradesh.

Author(s): Rajiv Rai

DOI: 10.5958/2231-5691.2016.00013.7 Access: Open Access Read More

Evaluation of Analgesic, Anti-Inflammatory of stem bark ethanolic Extract of Michelia champaca Linn

Author(s): K. N. S. Karthik, Konda Ravi Kumar

DOI: 10.5958/2231-5691.2017.00016.8 Access: Open Access Read More

Pharmacological Evaluation of Trichilia connaroides Bark for Analgesic and Anti-inflammatory activity in Experimental Animal Models

Author(s): Muhammed Shakkeel K.V, Anjan Kumar, Veeresh Babu. D, Narayana Swamy V.B

DOI: 10.5958/2231-5691.2015.00021.0 Access: Open Access Read More

Membrane Stabilization assay for Anti-inflammatory activity yields misleading results for samples containing traces of Methanol

Author(s): Govind Navale, Dipak D. Patil, Aashutosh A. Patil, Ketan B. Patil, Narendra B. Patil

DOI: 10.5958/2231-5691.2019.00026.1 Access: Open Access Read More

Synthesis of novel 3-[(dialkyl/aryl amino) methyl]-2-substituted-4(3H)-Quinazolinones and evaluation of their Anti-inflammatory activity

Author(s): Ganesh Akula, Rangu Nirmala, CH. Shanthipriya, S. Rohini Reddy, A. Jaswanth

DOI: 10.5958/2231-5691.2017.00010.7 Access: Open Access Read More

Studies on Anti-depressant and Anti-inflammatory Activities of Curcuma aromatica Rhizome in Experimental Animal Models

Author(s): Jaseela KP, Anjan Kumar, Veeresh Babu. D, Narayana Swamy V.B

DOI: 10.5958/2231-5691.2016.00014.9 Access: Open Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available
DOI: 10.5958/2231–5691